Endocrine homeostasis and metabolic diseases have been the subject of extensive
research in recent years. The development of new techniques and insights has led to a …

Summary Type 1 diabetes (T1D) is a chronic autoimmune disease targeting insulin‐
producing pancreatic beta cells. T1D is a multifactorial disease incorporating genetic and …

Advances in stem cell technology offer new possibilities for patients with untreated diseases
and disorders. Stem cell-based therapy, which includes multipotent mesenchymal stem cells …

Diabetes mellitus is a metabolic disease, characterized by chronic hyperglycemia caused by
an abnormality in insulin secretion or action. Millions of people across the world are affected …

Mesenchymal stem cells (MSCs) play a key role in wound healing, and the advantages of
pretreated MSCs in wound healing have previously been reported. In the present study, we …

Nearly 100 years ago, diabetes, a disease expected to reach global prevalence of at least
10% within the decade, was a fatal diagnosis. This year of 2022 marks a century since …

In this editorial, we offer our perspective on the groundbreaking study entitled “Hypoxia and
inflammatory factor preconditioning enhances the immunosuppressive properties of human …

Background Research on diabetes remission has garnered prominence in recent years.
However, to date, no pertinent bibliometric study has been published. This study sought to …

Various types of stem cells are being researched upon to exploit their potential for
regenerative medicine including pluripotent human embryonic stem (hES) cells derived from …

Diabetes Mellitus Type 1 is an autoimmune disease that occurs due to the destruction of
insulin-producing cells (β cells), resulting in hyperglycemia. Therefore, diabetic patients …